-
MedCity Influencers, Health Tech
Pharma Injecting Life into Digital Health Amidst Funding Downturn
Numerous clinical, regulatory and financial factors are behind this digital shift in pharma. Regardless of the reasons, investors, pharma, and research organizations are recognizing that advanced digital health tools will be a significant competitive advantage and generate meaningful return on investment (ROI) in an industry that is becoming more personalized and specialized.
-
Digital health investment undergoing a healthy reset, future to be defined by value
While 2022 will likely be a reset from the tremendous growth in digital health funding of 2021, this is a healthy correction and an opportunity to realign on core metrics.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.